Pisa, 20 October 2025 -Pharmanutra S.p.A. (MTA; Ticker PHN), a company specializing in mineral-based nutritional supplements and medical devices for muscles and joints, received an important award at the 16th edition of Spazio Nutrizione, held on October 17-18 at the NH Milano Congress Centre in Assago. At this important event, which brought together the scientific community and industry professionals, Pharmanutra received the Spazio Nutrizione 2025 "Partner" Award for the "Best Nutraceutical Product" of the year, awarded to SiderAL® Forte, nutritional supplement formulated for the effective treatment of iron deficiency, even in cases of severe deficiency or in individuals with low tolerance to traditional iron salts.
This is yet another recognition for one of the flagship products of the SiderAL® line, iron supplements based on the innovative Sucrosomiale® technology, a formulation that guarantees high intestinal absorption, maximum tolerability, and proven efficacy, significantly reducing the side effects typical of conventional supplementation such as nausea, constipation, gastric irritation, and metallic aftertaste. The innovative Sucrosomiale® technology is based on a structure called Sucrosoma®, which allows iron pyrophosphate to be wrapped in a matrix of phospholipids and fatty acid saccharide esters, promoting intestinal absorption without altering the stomach.
The award for "Best Nutraceutical Product" of the year given to SiderAL® Forte is not only recognition of the results achieved-we are talking about a leading product in the field of iron-based nutritional supplements-but also a true celebration of the values that drive the nutraceutical sector: innovation, expertise, and constant commitment to promoting health, which are the cornerstones of Pharmanutra's business.
1 Source: New Line Ricerche di Mercato
On behalf of the Pisa-based group, founded by brothers Andrea and Roberto Lacorte, the award was received by Pharmanutra's Chief Scientific Officer, Germano Tarantino, who expressed the company's satisfaction with the prize: "The award for Best Nutraceutical Product of the Year given to SiderAL® Forte is a very important recognition, the latest in a long series, which demonstrates how Sucrosomiale® technology, several years after its invention, is still at the forefront. Above all, it is recognition of our proprietary patented technology, which continues to be a step ahead of everything else that the scientific community, and therefore the market, offers doctors and nutritionists to solve a widespread problem such as iron deficiency. This award is particularly important to us because the committee evaluated the various projects-a panel of experts from the world of nutrition-based its decision on the evidence and scientific value of the product, as well as its practical application and resulting benefits. Such awards also represent an incentive to continue our intensive scientific research, with the aim of further improving Sucrosomiale® technology and applying it to other nutrients, as we have done with the vitamins in the Sidevit line that we launched this year".
Pharmanutra's attendance at the 16th edition of Spazio Nutrizione was further enhanced by the participation of Valerio Miale, Medical Affairs at Pharmanutra, who, as part of a rich scientific program, gave a presentation entitled "Iron status in athletes: challenges and considerations," which addressed issues related to iron status in athletes, a central theme for the prevention and management of iron deficiency in competitive and professional sports.
Pharmanutra was among the exhibitors at this important event, together with its subsidiary Akern Srl, a company specializing in biomedical technologies and advanced systems for body composition assessment, in a context that is a benchmark for doctors, nutritionists, researchers, and companies operating in the health and nutrition sector.
PharmaNutra S.p.A.Founded in 2003 in Pisa by Andrea and Roberto Lacorte, Pharmanutra is the holding company of an international Group engaged in the research, development, and commercialization of nutritional supplements, medical devices, and patented raw materials. A leader in iron-based supplements through its Sucrosomial® Technology (SiderAL® and Apportal®), and an emerging player in medical devices for mobility (Cetilar®), the Group internally manages the entire value chain and holds a solid portfolio of patents, brands, and clinical evidence. Pharmanutra operates in over 80 countries, with subsidiaries in the USA and Spain, and also includes Akern S.r.l. (bioimpedance analysis) and Athletica Cetilar S.r.l. (sports medicine).
PharmanutraGroup.com Pharmanutra.it
For more information:
PharmaNutra S.p.A. Press Office - Spriano Communication & PartnersVia Campodavela, 1 - 56122 Pisa
Tel. +39 050 7846500
investorrelation@PharmaNutra.it
Internal Press Office press@calabughi.com
Via Santa Radegonda, 16 - 20121 Milan Tel. +39 02 83635708
Matteo Russo mrusso@sprianocommunication.com Cristina Tronconi ctronconi@sprianocommunication.com